Multiple Gastric Carcinomas Associated with Potter Type III Cystic Disease by Mimatsu, Kenji et al.
Case Rep Gastroenterol 2011;5:590–596 
DOI: 10.1159/000329179 
Published online: 
October 7, 2011 
© 2011 S. Karger AG, Basel
ISSN 1662–0631 
www.karger.com/crg   
This is an Open Access article licensed under the terms of the Creative Commons Attribution-
NonCommercial-NoDerivs 3.0 License (www.karger.com/OA-license), applicable to the online
version of the article only. Distribution for non-commercial purposes only. 
 
 
Kenji Mimatsu, MD, PhD    Department of Surgery, Social Insurance Yokohama Central Hospital 
268 Yamashita-cho, Naka-ku, Yokohama, Kanagawa 231-8553 (Japan) 
Tel. +81 45 641 1921, E-Mail mimtatsu.kenji @ yokochu.jp 
 
590
   
Multiple Gastric Carcinomas 
Associated with Potter Type III 
Cystic Disease 
Kenji Mimatsua    Takatsugu Oidaa    Atsushi Kawasakia    
Hisao Kanoa    Kazutoshi Kidaa    Nobutada Fukinoa    
Youichi Kuboi
a    Sadao Amanob 
aDepartment of Surgery, Social Insurance Yokohama Central Hospital, Yokahama, 
and bDepartment of Surgery, Nihon University School of Medicine, Tokyo, Japan 
 
 
Key Words 
Gastric carcinoma · Polycystic disease · Polycystic liver and kidney disease 
Abstract 
We report a case of multiple gastric carcinomas associated with Potter type III cystic 
disease of the liver, mesenterium and kidney. A 65-year-old man with chronic renal 
failure due to polycystic kidneys and under hemodialysis treatment 3 times a week for 
2 years was admitted to our hospital because of anemia. He stated that his sister had 
suffered from polycystic kidney disease. Gastrointestinal fiberscopy showed two lesions 
in the lesser curvature in the lower portion of the stomach, and histopathological 
analysis of the gastric tumor biopsies revealed that one of the tumors was a papillary 
adenocarcinoma and the other a poorly differentiated adenocarcinoma. Helicobacter 
pylori infection was not detected in the stomach mucosa. Abdominal computed 
tomography scan revealed polycystic lesions in the liver, mesenterium and both kidneys. 
These imaging findings and family history suggested that the patient suffered from 
multiple gastric carcinomas associated with Potter type III cystic disease of the liver, 
mesenterium and kidney. Reports on the association of malignant neoplasm with Potter 
type III cystic disease are extremely rare. Especially, no case of the association of gastric 
carcinoma with Potter type III cystic disease of the liver and kidney has been described 
previously. This is a first report of the association of gastric carcinoma with Potter type III 
cystic disease. We also review reports of other malignant neoplasms associated with 
polycystic disease. Case Rep Gastroenterol 2011;5:590–596 
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Introduction 
Polycystic liver disease is a condition characterized by the presence of multiple cysts in 
the liver, which may be inherited or sporadic, and most cases of adult polycystic liver 
disease (APLD) are related to autosomal dominant polycystic kidney disease (ADPKD). 
In 1964, Osathanondh and Potter [1] classified polycystic kidney into three types. Potter 
type III cystic disease corresponds to the adult type of polycystic kidney. There have been 
some reports, till date, that describe the association of malignant neoplasms with Potter 
type III cystic disease of the liver and kidney [2–8]; however, most of these describe 
pancreatic and hepatobiliary neoplasms arising in patients with polycystic liver and 
kidney diseases including ADPKD, and no report has described the association of gastric 
carcinoma with Potter type III cystic disease of the liver and kidney. This is the first case 
report of multiple gastric carcinomas associated with Potter type III cystic disease of the 
liver, mesenterium and kidney. Although it is unclear whether the development of 
multiple gastric carcinomas is directly associated with the pathogenesis of multiple cysts 
in the liver, mesenterium and kidney, this case provides a perspective for etiology of 
gastric carcinoma with polycystic disease. 
Case Report 
A 65-year-old man was admitted to our hospital because of anemia. He had been receiving 
hemodialysis treatment 3 times a week for 2 years because of chronic renal failure due to polycystic 
kidneys. He stated that his sister had suffered from polycystic kidney disease. Physical examination on 
admission revealed distended abdomen due to polycystic disease. Laboratory examination revealed 
hemoglobinemia (8.5 g/dl). The result of the diagnostic tests for hepatitis B and C was negative. The 
patient had high serum levels of carcinoembryonic antigen (7.9 ng/ml) and carbohydrate antigen 
19-9 (202 mg/dl). An abdominal computed tomography scan showed multiple cysts in the liver 
and cystic lesions on both sides in the kidney and mesenterium (fig. 1). These findings suggested 
that he suffered from polycystic disease of the liver and kidney. Gastrointestinal fiberscopy showed 
the presence of two ulcerated lesions in the lesser curvature in the middle and lower portions of 
the stomach. Histopathological analysis of the gastric tumor biopsy specimens revealed papillary 
adenocarcinoma in one tumor and poorly differentiated adenocarcinoma in another. Distal gastrectomy 
with lymph node dissection was performed, and the gastric tumors were surgically diagnosed to be 
T2N1M0, stage II, according to the TNM classification for gastric carcinoma. Operative examination 
confirmed the presence of multiple cysts in the liver (fig. 2a) and on both sides in the kidney and 
mesenterium (fig. 2b). 
Macroscopic examination showed that two tumors of type II were present in the middle and lower 
portions of the stomach (fig. 3a). On the basis of a histopathological examination, the distal lesion was 
diagnosed as a poorly differentiated adenocarcinoma (38 × 39 × 6 mm) within the muscularis propria, 
with marked lymphatic invasion (ly2) and vascular invasion (v2) (fig. 3b); the lesion on the proximal 
side was diagnosed as a papillary adenocarcinoma (58 × 47 × 6 mm) within the submucosal layer, with 
marked lymphatic invasion (ly2) and vascular invasion (v1) (fig. 3c). Normal gastric mucosa was 
observed between the tumors. Lymph node metastases had occurred around the right gastroepiploic 
artery and right gastric artery. Helicobacter pylori infection was not detected in the stomach mucosa. 
Discussion 
ADPKD is the most common of all inherited renal cystic diseases and has various 
external manifestations, including cysts in the pancreas, seminal vesicles, arachnoid 
membrane, and liver [9]. Many classifications for cystic diseases of the kidney have been 
proposed. The most accepted among them is the Osathanondh and Potter system that was Case Rep Gastroenterol 2011;5:590–596 
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established in 1964, according to which polycystic kidneys are classified into three types 
[1]. Potter type III cystic disease involves one or more of several abnormalities. The cysts 
may be present in any portion of the nephron or tubule, but they are most commonly 
found in Bowman’s space and the angle of the loop of Henle. In the older classification, 
Potter type III cystic disease was considered to represent adult-type polycystic disease of 
the kidney. In 1972, Hatfield and Pfister pathologically examined 399 patients with 
multiple cysts in both kidneys [10]. They also observed cysts in the liver and/or pancreas 
in 58 of these patients; hence, they described this condition as Potter type III polycystic 
disease. In the present case, computed tomography and ultrasonography scans showed 
multiple renal and hepatic cysts in addition to multiple cysts in the mesenterium. 
Therefore, according to Hatfield and Pfister’s criteria [10], we considered that this case of 
association of APLD with multiple renal cysts could be classified as Potter type III cystic 
disease. The patient stated that his sister had suffered from polycystic kidney disease; 
however, we could not confirm the presence of a family history of polycystic kidney 
disease because his sister had been out of contact for long. In the absence of a family 
history of ADPKD, bilateral multiple renal cysts with hepatic cysts, together with the 
absence of other manifestations suggesting a different renal cystic disease, provide 
evidence for diagnosis [9]. In these instances, molecular genetic analysis is required. A 
family history, however, may be absent in 20–40% of new patients in whom the diagnosis 
of ADPKD first is suspected from imaging studies, which can be due to a de novo 
mutation of PKD-1 or PKD-2 genes [11]. Although we could not confirm the mutation of 
PKD-1 or PKD-2 in this case, family history, clinical findings and imaging studies 
suggested that the patient suffered from ADPKD. 
Reports on the association of malignant neoplasm with APLD and ADPKD (Potter 
type III cystic disease) are extremely rare. To our knowledge, only 8 such cases have 
been reported in the English language literature (table 1) [2–8]. Till date, most cases of 
neoplasms associated with polycystic disease of the liver and kidney have been reported as 
either pancreatic or hepatobiliary neoplasms, namely 5 cases of pancreatic neoplasms and 
3 cases of cholangiocarcinoma. Since 5 of these cases were pancreatic neoplasms, we think 
that ADPKD has some genetic influence on the development of pancreatic neoplasms. 
Aziz et al. [12] reported 2 patients from the same family (a brother and a sister) with 
ADPKD who developed adenocarcinoma of the gastroesophageal junction; however, 
these patients did not have cysts in the liver or other organs except for the kidney. In the 
present case, although a detailed family history could not be obtained, multiple cysts were 
observed in the liver, both kidneys, and mesenterium. 
ADPKD is caused by defects in PKD-1 or PKD-2 [13]. These genes encode a member 
of the polycystin protein family, which is an integral membrane protein that functions as 
a regulator of calcium-permeable cation channels and intracellular calcium homoeostasis 
[14]. Some studies have described an association between the PKD genes and cancer 
cells; polycystin-1, encoded by PKD-1, was reported to induce apoptosis and cell cycle 
arrest in the G0/G1 phase in cancer cells [14]. Moreover, PKD-1 inhibits cancer cell 
migration and invasion and may be considered a new member of the tumor suppressor 
family of genes [15]. These molecular studies suggested that PKD genes inhibit cancer 
progression. Therefore, ADPKD, which is caused by defective PKD-1 and PKD-2, may 
be a carcinogenic condition. In addition, mutations in two genes, namely PRKSCH 
(which codes for hepatocystin) and SEC63, have been found to cause APLD. However, Case Rep Gastroenterol 2011;5:590–596 
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as mutations in these genes have not been found in all families, undiscovered genes 
responsible for causing APLD probably still exist [13]. 
Although it is unclear whether the development of multiple gastric carcinomas is 
directly associated with the pathogenesis of cysts in the liver, mesenterium and kidney, 
the present case demonstrates that gastric carcinoma can be an external complication in 
patients with polycystic disease. 
Disclosure Statement 
None of the authors has any conflict of interest. 
 
 
 
Table 1. Malignant neoplasms associated with polycystic disease of the liver and kidney 
Case Refer-
ence 
First 
author 
Year Age  Sex  Family   
history 
Location of cyst  Hemo-
dialysis 
Neoplasms Treatment  for 
neoplasms 
1 2 Cryer  1977  66  F  PKD  kidney/liver  ND  panc.  adenocarcinoma  operation 
2 3 Landais 1984  52  F  ND  kidney/liver  done  chorangiocarcinoma  none 
3 3 Landais 1984  56  M  PKD  kidney/liver  done  chorangiocarcinoma  none 
4  4  Niv  1997  68  M  PKD  kidney/liver  not done  panc. cystadenocarcinoma  none 
5  5  Sakurai  2001  63  M  PKD/PLD  kidney/liver  not done  panc. ductal adenocarcinoma  none 
6 6 Sasaki  2002  60  M  PKD  kidney/liver  done  IHCC  none 
7 7 Naitou 2005  43  M  PKD  kidney/liver/panc.  ND  IPMT  operation  (PD) 
8  8  Sato  2009  63  M  none  kidney/liver/panc.  not done  IPMN  operation (PD) 
9  o.c.  Mimatsu  2011  65  M  ND  kidney/liver/mesen.  done  multiple gastric carcinomas  operation (G) 
G = Gastrectomy; IHCC = intrahepatic cholangiocarcinoma; IPMN = intraductal papillary mucinous neoplasm; IPMT = intraductal papillary 
mucinous tumor; mesen. = mesenterium; ND = not described; o.c. = our case; panc. = pancreas; PD = pancreaticoduodenectomy; PKD = polycystic 
kidney disease; PLD = polycystic liver disease. 
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Fig. 1. Abdominal computed tomography scan showed multiple cysts in the liver (a) and cystic lesions 
on both sides in the kidney (b). 
 
 
 
Fig. 2. Operative findings showed the presence of multiple cysts in the liver (a) and mesenterium (b). 
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Fig. 3. Macroscopic findings showed that two tumors of type II were present in the antral stomach. 
Normal gastric mucosa was observed between the tumors (a). Histopathological findings showed poorly 
differentiated adenocarcinoma in the distal tumor (b) and papillary adenocarcinoma in the proximal 
tumor (c). HE; ×100. 
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